{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:24:33Z","timestamp":1793831073566,"version":"4.6.1"},"reference-count":47,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fluoroquinolone prophylaxis\u2019s (FQ-P) usefulness in patients with neutropenia is controversial. In recent decades, Italian epidemiological data has shown worrisome rates of FQ resistance. A single-center cohort study on 136 autologous stem cell transplantations (ASCTs) and 223 allogeneic hematopoietic stem cell transplantations (allo-HSCTs) was performed from January 2018 to December 2020. Piperacillin\/tazobactam was the first-line therapy for febrile neutropenia (FN). Since February 2019, FQ-P has been omitted. We evaluated the day\u00a0+30 posttransplant cumulative incidence function (CIF) of gram-negative bacteria pre-engraftment bloodstream infections (PE-BSIs) and any changes in antimicrobial resistance, FN, and infection-related mortality (IRM). In ASCTs, \u22651 FN episode occurred in 74.3% of transplants, without differences among groups (P = .66). CIF of gram-negative bacteria PE-BSI was 10.1%, with a significant difference according to FQ-P (0% [LEVO-group] vs 14.1% [NO-LEVO-group], P = .016). CIF of IRM was 0% in both groups. In allo-HSCTs, \u22651 FN episode occurred in 96.4% of transplants, without differences among groups (P = .72). CIF of gram-negative bacteria PE-BSI was 28%, significantly higher without FQ-P (14.7% [LEVO-group] vs 34.4% [NO-LEVO-group], P = .003). CIF of IRM was 5%, superimposable in both groups (P = .62). Comparing antimicrobial resistance among gram-negative bacteria of allo-HSCT setting, in the group without FQ-P, a significantly higher proportion of pathogens was susceptible to piperacillin\/tazobactam (71% vs 30%, P = .026), FQ (49% vs 10%, P = .03), and carbapenems (95% vs 50%, P = .001). FQ-P discontinuation increased gram-negative bacteria PE-BSI but did not impact IRM, both in the ASCT and allo-HSCT settings; importantly, it concurred to significantly decrease antimicrobial resistance in gram-negative bacteria.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008226","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T12:46:01Z","timestamp":1669034761000},"page":"1621-1634","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB"],"prefix":"10.1182","volume":"7","author":[{"given":"Daniela","family":"Clerici","sequence":"first","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galli","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-5328","authenticated-orcid":false,"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Lugli","sequence":"additional","affiliation":[{"name":"3University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Erbella","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"},{"name":"3University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-0377","authenticated-orcid":false,"given":"Marco","family":"Ripa","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"},{"name":"3University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tassan Din","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Nitti","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"},{"name":"3University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giglio","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mastaglio","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lorentino","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Xue","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Farina","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0948-9343","authenticated-orcid":false,"given":"Carmine","family":"Liberatore","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Poli","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carletti","sequence":"additional","affiliation":[{"name":"4Laboratory of Medical Microbiology and Virology, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Lupo Stanghellini","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-4839","authenticated-orcid":false,"given":"Matteo G.","family":"Carrabba","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Assanelli","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1334-0851","authenticated-orcid":false,"given":"Massimo","family":"Bernardi","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4377-8571","authenticated-orcid":false,"given":"Consuelo","family":"Corti","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Peccatori","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-0910","authenticated-orcid":false,"given":"Nicasio","family":"Mancini","sequence":"additional","affiliation":[{"name":"3University Vita-Salute San Raffaele, Milan, Italy"},{"name":"4Laboratory of Medical Microbiology and Virology, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Scarpellini","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"1Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milan, Italy"},{"name":"3University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"},{"name":"3University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Oltolini","sequence":"additional","affiliation":[{"name":"2Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"issue":"7","key":"2023050514394245800_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"24","key":"2023050514394245800_bib2","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2023050514394245800_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2023050514394245800_bib4","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogenic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2023050514394245800_bib5","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.bbmt.2018.02.021","article-title":"Clinical impact of pretransplant multidrug-resistant gram-negative colonization in autologous and allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Forcina","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2023050514394245800_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bmt.2016.234","article-title":"Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation","volume":"52","author":"Forcina","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2023050514394245800_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejcsup.2007.06.002","article-title":"Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients","volume":"5","author":"Bucaneve","year":"2007","journal-title":"Eur J Cancer Suppl"},{"issue":"30","key":"2023050514394245800_bib8","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2023050514394245800_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"2023050514394245800_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","article-title":"Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas","volume":"353","author":"Cullen","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023050514394245800_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"issue":"8","key":"2023050514394245800_bib12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2023050514394245800_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2023050514394245800_bib14","first-page":"20","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J\u00a0Infect"},{"issue":"2","key":"2023050514394245800_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2011.10.009","article-title":"Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous hematopoietic stem cell transplantation: a randomised trial","volume":"39","author":"Vehreschild","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2023050514394245800_bib16","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","article-title":"Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy","volume":"32","author":"Laoprasopwattana","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2023050514394245800_bib17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"issue":"7","key":"2023050514394245800_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmi.2018.02.031","article-title":"Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?","volume":"24","author":"Mikulska","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2023050514394245800_bib19","unstructured":"European Centre for Disease Prevention and Control\n          . Antimicrobial resistance in the EU\/EEA (EARS-Net) \u2013 annual epidemiological report for 2020. Accessed 4 December 2022. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2020."},{"issue":"6","key":"2023050514394245800_bib20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2023050514394245800_bib21","doi-asserted-by":"crossref","first-page":"ofx215","DOI":"10.1093\/ofid\/ofx215","article-title":"Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant: results of a prospective study in adult patient","volume":"4","author":"Mancini","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"2023050514394245800_bib22","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2023050514394245800_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2023050514394245800_bib24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2023050514394245800_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2023050514394245800_bib26","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by Infectious Disease Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2023050514394245800_bib27","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2012.0146","article-title":"Prevention and treatment of cancer-related infections","volume":"10","author":"Baden","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"2023050514394245800_bib28","author":"Carreras","year":"2019","edition":"7th ed"},{"issue":"3","key":"2023050514394245800_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"2023050514394245800_bib30","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.jtct.2021.05.023","article-title":"Post-transplantation cyclophosphamide- and sirolimus-based graft-versus-host-disease prophylaxis in allogeneic stem cell transplant","volume":"27","author":"Greco","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"446","key":"2023050514394245800_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the sub-distribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"11","key":"2023050514394245800_bib32","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2023050514394245800_bib33","first-page":"882","article-title":"Intercontinental study on pre-engraftment and post-engraftment gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: risk factors and association with mortality","volume":"81","author":"Averbuch","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"6","key":"2023050514394245800_bib34","first-page":"1068","article-title":"Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance","volume":"70","author":"Martinez-Nadal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2023050514394245800_bib35","doi-asserted-by":"crossref","first-page":"e0174421","DOI":"10.1128\/AAC.01744-21","article-title":"Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock","volume":"66","author":"Chumbita","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2023050514394245800_bib36","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bbmt.2018.03.018","article-title":"De-escalation and discontinuation of empirical antibiotic treatment in a cohort of allogeneic hematopoietic stem cell transplantation recipients during the pre-engraftment period","volume":"24","author":"Gustinetti","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2023050514394245800_bib37","doi-asserted-by":"crossref","first-page":"e0004521","DOI":"10.1128\/AAC.00045-21","article-title":"Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)","volume":"65","author":"Albasanz-Puig","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2023050514394245800_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02494-19","article-title":"Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2023050514394245800_bib39","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1093\/cid\/ciaa1522","article-title":"Risk factors and outcomes of antibiotic-resistant Pseudomonas aeruginosa bloodstream infection in adult patients with acute leukemia","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2023050514394245800_bib40","doi-asserted-by":"crossref","first-page":"e13225","DOI":"10.1111\/tid.13225","article-title":"Incidence of febrile neutropenia in autologous hematopoietic stem cell transplant (HSCT) recipients on levofloxacin prophylaxis","volume":"22","author":"Signorelli","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"2023050514394245800_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ejh.13670","article-title":"Clinical and microbiological impact of long-term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia","volume":"107","author":"Verlinden","year":"2021","journal-title":"Eur J Haematol"},{"issue":"1","key":"2023050514394245800_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10096-004-1264-8","article-title":"Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility","volume":"24","author":"Mendelson","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"2023050514394245800_bib43","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/cid\/ciab404","article-title":"Colonization with fluoroquinolone-resistant Enterobacterales decreases the effectiveness of fluoroquinolone prophylaxis in hematopoietic cell transplant recipients","volume":"73","author":"Satlin","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2023050514394245800_bib44","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S1470-2045(19)30506-6","article-title":"Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial","volume":"20","author":"Drayson","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"2023050514394245800_bib45","first-page":"120","article-title":"Nanosphere's Verigene blood culture assay to detect multidrug-resistant gram-negative bacterial outbreak: a prospective study on 79 hematological patients in a country with high prevalence of antimicrobial resistance","volume":"1","author":"Greco","year":"2019","journal-title":"Clin Hematol Int"},{"issue":"10","key":"2023050514394245800_bib46","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"2023050514394245800_bib47","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","article-title":"Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO\/DGHO)","volume":"100","author":"Classen","year":"2021","journal-title":"Ann Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/9\/1621\/2049019\/blooda_adv-2022-008226-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/9\/1621\/2049019\/blooda_adv-2022-008226-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:40:25Z","timestamp":1683283225000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/9\/1621\/493295\/Levofloxacin-prophylaxis-vs-no-prophylaxis-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,5,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008226","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]}}}